Beneficiaries
The beneficiary member of Vaud BioMed are companies in the pharma, biotech, medtech, diagnostics, digital health, nutrition etc. that are present in the canton of Vaud and are likely to be interested in the services offered by service providers members of Vaud BioMed .
List of Beneficiaries
|
Debiopharm is focused on the development of innovative prescription drugs that target unmet medical needs. Our main therapeutics areas are oncology, infectious diseases and orphan drugs.
|
|
Elanix develops and commercializes tissue regeneration products for acute wound care, dermatological and gynaecological applications. It also provides services in cell therapy and related technologies.
|
|
Incyte’s is a leading global biopharmaceutical company, with a therapeutic focus in oncology. Incyte is a company founded on the premise that investment in good science and the rigorous pursuit of R&D excellence can translate into new medicines that can positively affect patients’ lives.Paragraph.
|
|
Valtronic innovates and manufactures miniaturized and high-precision complex products for its worldwide medical device partners.
|
Advantages for beneficiaries
Why join the Association Vaud BioMed?
- Participation in the promotion of our region through the life-sciences sector - in the interest of one and all.
- Free access to training sessions organised by the Association.
- Free access to events organised by the Association.
- Facilitated access to services offered at a special rate by highly specialised local service providers.
- Identification/recruitment of highly specialised human resources, access to ad interim HR when urgently needed.
- For foreign companies arriving in Switzerland, easier access to staff specialised in «one-stop-shop».